Copyright © 2005 by the Johns Hopkins Bloomberg School of Public Health
SPECIAL ARTICLE |
David Bodians Contribution to the Development of Poliovirus Vaccine
From the Departments of Microbiology and Neurology, School of Medicine, University of Pennsylvania, Philadelphia, PA.
Received for publication September 22, 2004; accepted for publication October 18, 2004.
Abbreviations: MV, mixed virus.
| The first 150 words of the full text of this article appear below. |
| INTRODUCTION |
|---|
David Bodian spent almost his whole scientific career (19421983) at the Johns Hopkins University, first in the Department of Epidemiology at the School of Hygiene and Public Health and then in the Department of Anatomy at the School of Medicine. Arguably, his most important research contribution was the elucidation of the pathogenesis of poliomyelitisa contribution that played a major role in the development of inactivated poliovirus vaccine (Salk vaccine), the first successful vaccine against poliomyelitis. In this historical review, I have chosen to focus on those aspects of Bodians research that were relevant to vaccine development. This retelling of the story is necessarily biased, since it emphasizes the work of one investigator while acknowledging that less attention is paid to the work of many others who made important contributions. In addition, I distort history somewhat by presenting the research results in an apparently logical sequence, while in truth the story
| PATHOGENESIS OF POLIOMYELITIS |
|---|
| PROTECTIVE ROLE OF ANTIBODY AND FORMULATION OF A VACCINE |
|---|
| REPRISE |
|---|